search-icon
AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Israel orders more Arrow 3 missiles, rushes Arrow 4 to meet hypersonic threats
2
Oracle CEO: "Some of the best people in the world are here in Israel, and there's no question about that"
3
AT&T buys $650M stake in DriveNets, delivering major payout to founders, employees and early backers
4
Mapping Israel’s $20B GenAI boom: 342 startups and counting
5
Underground mapping startup Exodigo raises $96M, hits $700M valuation
More news Buzzmore

Sisram Medical

5 stories about Sisram Medical
מימין קאלואן פוסון ויליאם הו פוסום ליאור דיין מיסטר לואי

Fosun Whetted Our Appetite, Says Alma Lasers CEO

04.07.19|Golan Hazani
Fosun Pharma CEO Yifang Wu and Alma Lasers CEO Lior Dayan gave Calcalist their first joint interview since the Chinese conglomerate acquired the Israeli medical laser company in 2013
בכירי פוסון אלמא לייזרס וחברת נכסי קיסריה עם השק אלי כהן בטקס ב קיסריה

Fosun Pharma Inaugurates New Building for Israeli Subsidiary Sisram Medical

26.02.19|Golan Hazani
Fosun paid $240 million for a 95% stake in the Israeli cosmetic surgery in 2014, floating it on the Hong Kong Exchange in 2017
קיסריה קמפוס גרניט 2

Fosun Pharma Subsidiary Sisram Medical Leases 11,000-Square-Meter Building in Caesarea

10.12.18|Dotan Levy
The ten-year lease is estimated at $1.7 million (NIS 6.3 million) per year. China’s Fosun Pharma bought Sisram in 2014 for $240 million, renaming it from Alma Lasers
בורסת הונג קונג בורסה בורסות אסיה

Sisram Stock Price Down on Market Debut

19.09.17|Amarelle Wenkert
The Fosun Pharma subsidiary debuted on the Hong Kong Stock Exchange Tuesday
בורסת הונג קונג בורסה בורסות אסיה

Sisram Medical Seeks to Raise Up To $176 Million in Hong Kong IPO

10.09.17|Amarelle Wenkert
On September 5, the Fosun Pharma subsidiary submitted a prospectus to the Hong Kong Stock Exchange
ProfilesEngineServlet?at=39&mi=10&pt=18&dpi=1243103233&pai=cTech&dpn=4409&mt=1